Patent directory · USPTO A61K / A61P
Patents matching “ABBVIE INC [US]”
30 pharma patents match "ABBVIE INC [US]" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 30 pharmaceutical patents matching "ABBVIE INC [US]" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 2021128573
DOSING REGIMENS FOR USE IN TREATING MYELOFIBROSIS AND MPN-RELATED DISORDERS WITH NAVITOCLAX
granted -
EP 3668502
MAKROCYCLISCHE MCL-1-INHIBITOREN UND VERFAHREN ZUR VERWENDUNG
granted -
US 2020155578
Pharmaceutical Formulations for Subcutaneous Administration
granted -
US 2019144465
Macrocyclic MCL-1 inhibitors and methods of use
granted -
US 2019055264
Macrocyclic MCL-1 inhibitors and methods of use
granted -
US 2017349653
METHODS FOR TREATING SPINAL CORD INJURY AND PAIN
granted